Merck Announces Third-Quarter 2024 Financial Results

Go back to Merck Announces Third-Quarter 2024 Financial Results

Leerink Partners Reiterates Outperform Rating on Merck (MRK)

November 1, 2024 7:20 AM EDT

Leerink Partners analyst Joseph P. Schwartz reiterated an Outperform rating on Merck (NYSE: MRK).

The analyst comments "Bottom Line: Gardasil remained the primary topic for Merck (MRK, OP) earnings and continues to weigh on the stock, which is trading at a 13.6 PE multiple, below most of its... More